Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease
- PMID: 15481315
- DOI: 10.1023/b:ddas.0000042242.22898.d9
Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease
Abstract
Oxidative stress and depletion of antioxidants may play a key role in the pathogenesis of inflammatory bowel disease (IBD)-related intestinal damage. A new automated assay for the determination of blood total antioxidant capacity (TAC), based on the crocin bleaching method, has been used for the measurement of TAC and corrected TAC (cTAC) in patients with ulcerative colitis (UC) and Crohn's disease (CD) in comparison to healthy controls (HC). Ninety-four patients with UC, 97 patients with CD, and 72 HC were included in this study. Serum TAC was measured in all patients and controls on an Olympus AU-600 chemistry analyzer using a TAC kit. cTAC was calculated from TAC after subtraction of the interactions due to endogenous uric acid, bilirubin and albumin. Mean serum TAC as well as cTAC levels were significantly lower in both UC and CD patients compared with HC (P < 0.0001). Patients with active UC had no different TAC and cTAC compared to those with inactive disease. Patients with active CD had significantly lower mean TAC compared to those with inactive disease but cTAC was not different between the two phases of disease activity. Patients with proctitis had significantly higher TAC and cTAC compared to patients with left-sided colitis and total colitis. In CD patients no association between disease localization and these markers was found. TAC and cTAC are significantly reduced in IBD patients compared with controls irrespective of disease activity. The decreased antioxidant defenses may be a primary phenomenon severely compromising the mucosa and therefore increase susceptibility to oxidative tissue damage.
Similar articles
-
Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.Medicina (Kaunas). 2019 Apr 2;55(4):88. doi: 10.3390/medicina55040088. Medicina (Kaunas). 2019. PMID: 30986917 Free PMC article.
-
Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.Inflamm Bowel Dis. 2006 Feb;12(2):100-5. doi: 10.1097/01.MIB.0000200345.38837.46. Inflamm Bowel Dis. 2006. PMID: 16432373
-
[Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].Przegl Lek. 2010;67(12):1262-5. Przegl Lek. 2010. PMID: 21591350 Polish.
-
Inflammatory bowel diseases: controversies in the use of diagnostic procedures.Dig Dis. 2009;27(3):269-77. doi: 10.1159/000228560. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786751 Review.
-
Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.World J Gastroenterol. 2014 Mar 28;20(12):3231-44. doi: 10.3748/wjg.v20.i12.3231. World J Gastroenterol. 2014. PMID: 24696607 Free PMC article. Review.
Cited by
-
Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.Medicina (Kaunas). 2019 Apr 2;55(4):88. doi: 10.3390/medicina55040088. Medicina (Kaunas). 2019. PMID: 30986917 Free PMC article.
-
Effect of ethanolic extract of leaves of Paederia foetida Linn. on acetic acid induced colitis in albino rats.Indian J Pharmacol. 2013 Sep-Oct;45(5):453-7. doi: 10.4103/0253-7613.117728. Indian J Pharmacol. 2013. PMID: 24130378 Free PMC article.
-
Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel.Oxid Med Cell Longev. 2016;2016:2325162. doi: 10.1155/2016/2325162. Epub 2015 Dec 28. Oxid Med Cell Longev. 2016. PMID: 26823944 Free PMC article. Review.
-
Validation of an automated assay for the measurement of cupric reducing antioxidant capacity in serum of dogs.BMC Vet Res. 2016 Jul 2;12(1):137. doi: 10.1186/s12917-016-0760-2. BMC Vet Res. 2016. PMID: 27370026 Free PMC article.
-
Screening for Chemical Characterization and Pharmacological Properties of Different Extracts from Nepeta italica.Plants (Basel). 2023 Jul 27;12(15):2785. doi: 10.3390/plants12152785. Plants (Basel). 2023. PMID: 37570939 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical